Collegium Pharmaceutical

Collegium Pharmaceutical COLL Stock

$25.55   0.471879%
Add to favorites
Market Cap
$793.98M
LOW - HIGH [24H]
$25.00 - $25.66
VOLUME [24H]
$365.22K
P/E Ratio
23.44
Earnings per share
$1.09
ISIN
US19459J1043
Price   Prediction

Collegium Pharmaceutical Price Chart

Sorry, that's all we've gotfor now...

Collegium Pharmaceutical (COLL) stock price today is 25.55 USD on Tech Market Large (+0.47% on the day). Updated .

Collegium Pharmaceutical COLL Financial and Trading Overview

Collegium Pharmaceutical stock price 25.55 USD
Previous Close 25.32 USD
Open 25.68 USD
Bid 18.24 USD x 200
Ask 32.25 USD x 200
Day's Range 25.04 - 25.68 USD
52 Week Range 21.43 - 50.79 USD
Volume 494.89K USD
Avg. Volume 776.6K USD
Market Cap 790.25M USD
Beta (5Y Monthly) 0.728
PE Ratio (TTM) 23.330275
EPS (TTM) 1.09 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 44 USD

COLL Valuation Measures

Enterprise Value 1.85B USD
Trailing P/E 23.330275
Forward P/E 3.592894
PEG Ratio (5 yr expected) 0.74
Price/Sales (ttm) 0.96940833
Price/Book (mrq) 2.6656184
Enterprise Value/Revenue 2.274
Enterprise Value/EBITDA 4.417

Trading Information

Collegium Pharmaceutical Stock Price History

Beta (5Y Monthly) 0.728
52-Week Change -44.15%
S&P500 52-Week Change 13.32%
52 Week High 50.79 USD
52 Week Low 21.43 USD
50-Day Moving Average 23.04 USD
200-Day Moving Average 32.16 USD

COLL Share Statistics

Avg. Volume (3 month) 776.6K USD
Avg. Daily Volume (10-Days) 713.36K USD
Shares Outstanding 31.08M
Float 28.29M
Short Ratio 7.8
% Held by Insiders 1.64%
% Held by Institutions 127.68%
Shares Short 5.19M
Short % of Float 20.16%
Short % of Shares Outstanding 16.71%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 4.68%
Operating Margin (ttm) 22.90%
Gross Margin 89.40%
EBITDA Margin 51.47%

Management Effectiveness

Return on Assets (ttm) 6.30%
Return on Equity (ttm) 13.36%

Income Statement

Revenue (ttm) 815.19M USD
Revenue Per Share (ttm) 25.49 USD
Quarterly Revenue Growth (yoy) 3.30%
Gross Profit (ttm) 728.78M USD
EBITDA 419.62M USD
Net Income Avi to Common (ttm) 38.17M USD
Diluted EPS (ttm) 1.09
Quarterly Earnings Growth (yoy) -30.89%

Balance Sheet

Total Cash (mrq) 144.8M USD
Total Cash Per Share (mrq) 4.66 USD
Total Debt (mrq) 1.21B USD
Total Debt/Equity (mrq) 407.38 USD
Current Ratio (mrq) 1.014
Book Value Per Share (mrq) 9.54

Cash Flow Statement

Operating Cash Flow (ttm) 338.02M USD
Levered Free Cash Flow (ttm) 366.99M USD

Profile of Collegium Pharmaceutical

Country United States
State MA
City Stoughton
Address 100 Technology Center Drive
ZIP 02072
Phone 781 713 3699
Website https://www.collegiumpharma.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 423

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. Collegium Pharmaceutical, Inc. was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. The company was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Q&A For Collegium Pharmaceutical Stock

What is a current COLL stock price?

Collegium Pharmaceutical COLL stock price today per share is 25.55 USD.

How to purchase Collegium Pharmaceutical stock?

You can buy COLL shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Collegium Pharmaceutical?

The stock symbol or ticker of Collegium Pharmaceutical is COLL.

Which industry does the Collegium Pharmaceutical company belong to?

The Collegium Pharmaceutical industry is Drug Manufacturers - Specialty & Generic.

How many shares does Collegium Pharmaceutical have in circulation?

The max supply of Collegium Pharmaceutical shares is 31.08M.

What is Collegium Pharmaceutical Price to Earnings Ratio (PE Ratio)?

Collegium Pharmaceutical PE Ratio is 23.44036500 now.

What was Collegium Pharmaceutical earnings per share over the trailing 12 months (TTM)?

Collegium Pharmaceutical EPS is 1.09 USD over the trailing 12 months.

Which sector does the Collegium Pharmaceutical company belong to?

The Collegium Pharmaceutical sector is Healthcare.

Collegium Pharmaceutical COLL included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24328.38 USD —
-0.74
8.59B USD — 23989.09 USD — 24547.66 USD — — 8.59B USD —
us US Tech Biotechnology Total Retu XNBI US 7668.49 USD —
-0.71
— — 7593.62 USD — 7712.43 USD — — — —
us US Tech Global Select Market Com NQGS US 11984.26 USD —
-0.73
— — 11815.78 USD — 12090.12 USD — — — —
us US Tech Biotechnology NBI US 7017.81 USD —
-0.71
— — 6949.3 USD — 7058.02 USD — — — —
us US Tech Health Care IXHC US 1332.89 USD —
-0.73
— — 1323.81 USD — 1342.94 USD — — — —
us US Tech Composite Total Return XCMP US 30064.18 USD —
-0.74
— — 29644.9 USD — 30335.16 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
$2.18T
Total marketcap
$72.01B
Total volume
BTC 59.04%   •   ETH 10.04%
Dominance
Select currency